Koenig Sheldon L. (CIK 1766524) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-18). Recent activity: Sell ESPR (53,588 shares), Sell ESPR (25,578 shares), Buy ESPR (723,760 shares), Sell ESPR (48,244 shares), Sell ESPR (28,427 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Esperion Therapeutics, Inc. (ESPR) | President and CEO | Sell | 53,588 | $169,070 |
| 2026-03-18 | Esperion Therapeutics, Inc. (ESPR) | President and CEO | Sell | 25,578 | $69,572 |
| 2026-03-16 | Esperion Therapeutics, Inc. (ESPR) | President and CEO | Buy | 723,760 | $0 |
| 2025-12-18 | Esperion Therapeutics, Inc. (ESPR) | President and CEO | Sell | 48,244 | $177,055 |
| 2025-09-18 | Esperion Therapeutics, Inc. (ESPR) | President and CEO | Sell | 28,427 | $79,311 |
| 2025-06-18 | Esperion Therapeutics, Inc. (ESPR) | President and CEO | Sell | 30,474 | $33,826 |
| 2025-03-19 | Esperion Therapeutics, Inc. (ESPR) | President and CEO | Sell | 13,047 | $19,570 |
| 2025-03-17 | Esperion Therapeutics, Inc. (ESPR) | President and CEO | Buy | 840,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-18